We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Catalyst Biosciences Announces Positive Top-Line Data for Potential Hemophilia B Treatment

News   Feb 12, 2018 | Original story from Catalyst Biosciences

 
Catalyst Biosciences Announces Positive Top-Line Data for Potential Hemophilia B Treatment

Novel Protease Drug

 
 
 

RELATED ARTICLES

Nanotechnology Approach for Treating Aggressive Breast Cancer

News

Triple negative breast cancer has no currently approved targeted therapies for treatment. Utilizing nanotechnology, a research group have developed a method that targets specific genes in triple negative breast cancer, killing cancerous cells.

READ MORE

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

European Bioinformatics Institute Launches Protein Data Bank

News

EMBL’s European Bioinformatics Institute (EMBL-EBI) and collaborators have launched a new data resource, called Protein Data Bank in Europe Knowledge Base (PDBe-KB), which gives researchers a more comprehensive view of publicly available protein structure data.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE